In women with signs of ischemia but no obstructive coronary artery disease (OCAD), intensive medical therapy did not reduce the first occurrence of a major cardiovascular event in the WARRIOR trial, but the trial was underpowered to show a definitive result. “This is a neutral trial and should not be considered a negative trial,” said ...
.png)
Market Touch Signal · Finland · international digital desk
+358 400 512311
info@market-touch.org
